Inside Navion: Employee Voices – Monica Gindhart
Meet Monica Gindhart, Navion’s powerhouse Director of Account Management.
Articles
How employers and TPAs can ease the rising cost of specialty drugs with medical rebates
It’s critical for all employers to explore medical rebate opportunities, where they can, to mitigate costs.
Inside Navion: Employee Voices – Giorgio Vescera
Meet Giorgio Vascera, Navion’s Senior Director of Consulting and Analytics.
Stay Informed, Stay Ahead: CVS’s Transition from Humira to Biosimilars
Earlier this month, CVS announced a major change to some of their formularies. This includes the removal of Humira, a widely used medication.
Spotlight: Featured on Self-Funded with Spencer Podcast
Brian Shonat, Goodroot’s area vice president of business development, recently joined Spencer Smith on the Self-Funded with Spencer podcast
Levemir Discontinuation: What You Need to Know
Important update regarding a recent development about Novo Nordisk’s announcement to discontinue Levemir.
Beyond Unit Cost: Evaluating Clinical Programs and Capabilities of PBMs
Here are three major factors brokers and employer groups should consider beyond unit cost when choosing a PBM.
